adolescents and young adults who have risk(s) of HCV infection Hepatitis C virus (HCV), adolescents, young adults, prevalence, sofosbuvir/ velpatasvir, knowledge and attitude, treatment literacy
Conditions
Interventions
Adolescents and young adults aged 15-24 years old with presence of any risk factor: HIV-infected patient, having anal sex, having multiple sexual partners, as in the last six months, having more than
Screening
adolescents and young adults who have risk(s) of HCV infection
Sponsors
Ratchadaphiseksomphot Endowment Fund
Division of AIDS and STIs, Department of Disease Control, Ministry of Public Health
Eligibility
Sex/Gender
All
Age
15 Years to 24 Years
Inclusion criteria
Inclusion criteria: Adolescents and young adults aged 15-24 years old who obtain voluntary consent to participate in a research project with the presence of any of the following risk factors will constitute a cause for the inclusion of the participant: HIV-infected patient, having anal sex, having multiple sexual partners, as in the last six months, having more than 1 partner, or having a history of substance abuse
Exclusion criteria
Exclusion criteria: The participant who had an HCV infection or had been cured before or ever had an anti-HCV screening for less than 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive for anti-HCV antibody at 1 day after enrollment Rapid anti-HCV antibody test | — |
Secondary
| Measure | Time frame |
|---|---|
| Knowledge and attitude at 1 day after enrollment questionare | — |
Countries
Thailand
Contacts
Public ContactKrisanee Pansue
Faculty of Medicine,Chulalongkorn University
Outcome results
None listed